KR20070083638A - 스태필로코커스 아우레우스 철포획체의 억제제에 대한스크리닝 분석 - Google Patents

스태필로코커스 아우레우스 철포획체의 억제제에 대한스크리닝 분석 Download PDF

Info

Publication number
KR20070083638A
KR20070083638A KR1020077007982A KR20077007982A KR20070083638A KR 20070083638 A KR20070083638 A KR 20070083638A KR 1020077007982 A KR1020077007982 A KR 1020077007982A KR 20077007982 A KR20077007982 A KR 20077007982A KR 20070083638 A KR20070083638 A KR 20070083638A
Authority
KR
South Korea
Prior art keywords
seq
leu
sbn
ile
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020077007982A
Other languages
English (en)
Korean (ko)
Inventor
데이비드 이. 하인리치스
수잔나 데일
Original Assignee
더 유니버시티 오브 웨스턴 온타리오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 유니버시티 오브 웨스턴 온타리오 filed Critical 더 유니버시티 오브 웨스턴 온타리오
Publication of KR20070083638A publication Critical patent/KR20070083638A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1020077007982A 2004-09-08 2005-09-08 스태필로코커스 아우레우스 철포획체의 억제제에 대한스크리닝 분석 Withdrawn KR20070083638A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60789604P 2004-09-08 2004-09-08
US60/607,896 2004-09-08

Publications (1)

Publication Number Publication Date
KR20070083638A true KR20070083638A (ko) 2007-08-24

Family

ID=36203330

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077007982A Withdrawn KR20070083638A (ko) 2004-09-08 2005-09-08 스태필로코커스 아우레우스 철포획체의 억제제에 대한스크리닝 분석

Country Status (7)

Country Link
US (1) US20110206685A1 (cg-RX-API-DMAC7.html)
EP (1) EP1786907A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008512108A (cg-RX-API-DMAC7.html)
KR (1) KR20070083638A (cg-RX-API-DMAC7.html)
AU (1) AU2005297171A1 (cg-RX-API-DMAC7.html)
CA (1) CA2576643A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006043182A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8637657B2 (en) 2008-08-19 2014-01-28 David E. Heinrichs Siderophore-mediated iron uptake in bacterial infection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000868A1 (en) * 1992-06-26 1994-01-06 Materials Research Corporation Transport system for wafer processing line
AU2002306849A1 (en) * 2001-03-21 2002-10-08 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
GB0107661D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
AU2002353764A1 (en) * 2001-06-17 2003-03-18 D-Squared Biotechnologies, Inc. Staphylococci surface-exposed immunogenic polypeptides
US6605459B2 (en) * 2001-07-13 2003-08-12 Paradigm Genetics, Inc. Methods for measuring cysteine and determining cysteine synthase activity
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms

Also Published As

Publication number Publication date
CA2576643A1 (en) 2006-04-27
WO2006043182A2 (en) 2006-04-27
WO2006043182A3 (en) 2006-09-21
EP1786907A2 (en) 2007-05-23
AU2005297171A1 (en) 2006-04-27
JP2008512108A (ja) 2008-04-24
EP1786907A4 (en) 2009-01-21
US20110206685A1 (en) 2011-08-25

Similar Documents

Publication Publication Date Title
WO2008152447A2 (en) Staphylococcus aureus specific anti-infectives
KR20070085457A (ko) 스태필로코쿠스 아우레우스의 철에 의해 조절되는 표면결정인자 IsdA, IsdB, 및 IsdC 기재 백신,조성물 및 방법
KR20030003221A (ko) 대장균 증식에 필요한 유전자
CN114088946A (zh) 转录调控因子WalR和MgrA的亚硝基化修饰在治疗金黄色葡萄球菌感染中的应用
US20080050361A1 (en) Staphylococcus aureas specific anti-infectives
US20040157314A1 (en) Inhibitors of Staphylococcus aureus primary sigma factor and uses thereof
CN102203268A (zh) 细菌感染中铁载体介导的铁摄取
JP5265188B2 (ja) Staphylococcusaureusにおける鉄輸送阻害剤を同定する方法
JPH10113189A (ja) 新規 RNaseP
US20110206685A1 (en) Screening assays for inhibitors of a staphylococcus aureus siderophore
US8729013B2 (en) Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
JPH11235183A (ja) シグナル認識粒子ポリペプチドおよびポリヌクレオチド
JPH1198993A (ja) 新規化合物
JP2001514025A (ja) 新規rnasep
JPH11337548A (ja) 新規DbpB
JP4270466B2 (ja) NADase、SNIおよびSLO遺伝子を含むオペロンから発現するタンパク質の製造方法、それにより得られるタンパク質およびその使用
JP2004515251A (ja) スタフィロコッカス・アウレウス必須遺伝子及びそのコードされるタンパク質staau_r9に関連する組成物及び方法
JPH11285389A (ja) 新規ftsY
JPH11155582A (ja) 新規GlmU
US20100129349A1 (en) Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
US20070292873A1 (en) Bacterial iron acquisition targets
JP2002525048A (ja) Rnasepポリペプチド
JPH11253170A (ja) FtsY
WO2003092587A2 (en) Modulation of bacterial membrane permeability
HK1258877A1 (en) A novel endolysin polypeptide

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20070406

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid